Skip Navigation

Annals of Oncology 2006 17(Supplement 7):vii51-vii54; doi:10.1093/annonc/mdl951
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Labianca, R.
Right arrow Articles by Garassino, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labianca, R.
Right arrow Articles by Garassino, M. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

symposium article

New strategies in colon cancer adjuvant therapy

R. Labianca1, S. Mosconi1 and M. C. Garassino2

1 Oncology Unit Ospedali Riuniti, Bergamo, Italy; 2 Oncology Department Ospedale Fatebenefratelli e Oftalmico, Milano, Italy

*Correspondence to: R. Labianca, Medical Oncology Unit, Ospedali Riuniti Largo Barozzi, 1 24128 Bergamo, Italy. Tel: 35-269859; Fax: 35-266849; E-mail: rlabian{at}tin.it

Adjuvant therapy in colorectal cancer has always been a controversy during years. Despite the fact that benefit of adjuvant therapy in stage III is clear, a more controversial question concerns efficacy in stage II. The introduction of new drugs in addition to standard regimens has some benefit, but also adds toxicity. Ongoing studies with novel targeted therapies will show their results in the next years. Other open questions include duration of therapy and whether there is a real possibility of selecting patients for treatment on the basis of prognostic factors.

Key words: colon cancer, adjuvant therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.